The Centers for Disease Control and Prevention (CDC) approved the use of the Pfizer/BioNTech vaccine for the age group on November 2. Since then, 4.2 million children ages 5 to 11 have received at least their first COVID-19 shot — about 15% of the age group.
In November, the newly eligible group accounted for 36% of all people starting vaccination.